21 May 2019 : Clinical Research
Non-Medical Use of Prescription Stimulants for Treatment of Attention Disorders by University Students: Characteristics and Associations
Liat Korn1ABCDEF*, Kineret Hassan1CDEF, Nadya Fainshtein1CDEF, Nizmit Yusov1CDEF, Nitza Davidovitch2ACDEFGDOI: 10.12659/MSM.913973
Med Sci Monit 2019; 25:3778-3787
Abstract
BACKGROUND: Non-medical use of prescription stimulants (NPS) for treatment of attention deficit hyperactivity disorders (ADHD), which are considered narcotic substances and medical drugs, are used to treat learning and attention disorders. The purpose of this study was to investigate associations between misuse of medications for treatment of ADHD and various characteristics and problem behaviors, such as impulsivity, deviant behavior, and drug use.
MATERIAL AND METHODS: A total of 1280 undergraduate students (64% females; mean age 27; SD=6) completed an anonymous, structured, self-report questionnaire on health, well-being, and health risk behaviors.
RESULTS: NPS for treatment of ADHD was significantly associated with cannabis AOR (adjusted odds ratio)=5.57, P<0.001, compared to non-users. Deviant behaviors were significantly more prevalent among students engaging in medical use of prescription stimulants for treatment of ADHD (P=0.01; 43.2% and misuse 51.1%) versus non-users (34.5%).
CONCLUSIONS: Social attention in needed and implementing of social policy to raise students’ awareness of the problems involved in misuse of medications for treatment of ADHD, to form intervention programs tailored for students, and to refer students for appropriate counseling and diagnosis.
Keywords: Attention Deficit and Disruptive Behavior Disorders, Cannabis, Prescription Drug Misuse, Risk-Taking, Students, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Cognition Disorders, Impulsive Behavior, Israel, Marijuana Smoking, Methylphenidate, Prevalence, Substance-Related Disorders, Universities, young adult
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952